39 related articles for article (PubMed ID: 33162513)
1. Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors.
Yavvari S; Makena Y; Sukhavasi S; Makena MR
Children (Basel); 2019 Nov; 6(12):. PubMed ID: 31795500
[TBL] [Abstract][Full Text] [Related]
2. Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study.
Junk SV; Förster A; Schmidt G; Zimmermann M; Fedders B; Haermeyer B; Bergmann AK; Möricke A; Cario G; Auber B; Schrappe M; Kratz CP; Stanulla M
Leukemia; 2024 Apr; 38(4):887-892. PubMed ID: 38413718
[No Abstract] [Full Text] [Related]
3. Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature.
Trobaugh-Lotrario A; Watanabe K; O'Neill AF; Dembowska-Bagińska B; Häberle B; Murphy A; Hiyama E; Czauderna P; Meyers RL; Langham M; Feusner J
J Pediatr Hematol Oncol; 2024 Mar; 46(2):80-87. PubMed ID: 38316145
[TBL] [Abstract][Full Text] [Related]
4. Current knowledge and future research directions in treatment-related second primary malignancies.
Morton LM; Swerdlow AJ; Schaapveld M; Ramadan S; Hodgson DC; Radford J; van Leeuwen FE
EJC Suppl; 2014 Jun; 12(1):5-17. PubMed ID: 26217162
[TBL] [Abstract][Full Text] [Related]
5.
Zhang X
Case Rep Oncol; 2023; 16(1):893-899. PubMed ID: 37900834
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.
Lopez-Lopez E; Autry RJ; Smith C; Yang W; Paugh SW; Panetta JC; Crews KR; Bonten EJ; Smart B; Pei D; McCorkle JR; Diouf B; Roberts KG; Shi L; Pounds S; Cheng C; Mullighan CG; Pui CH; Relling MV; Evans WE
J Clin Invest; 2020 Dec; 130(12):6600-6615. PubMed ID: 33164984
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia.
Lühmann JL; Stelter M; Wolter M; Kater J; Lentes J; Bergmann AK; Schieck M; Göhring G; Möricke A; Cario G; Žaliová M; Schrappe M; Schlegelberger B; Stanulla M; Steinemann D
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503197
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.
Bhatia S
Cancer; 2015 Mar; 121(5):648-63. PubMed ID: 25355167
[TBL] [Abstract][Full Text] [Related]
9. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
10. [Genetic basis of subsequent malignant neoplasms].
Yoshida M; Kato M
Rinsho Ketsueki; 2020; 61(9):1174-1178. PubMed ID: 33162513
[TBL] [Abstract][Full Text] [Related]
11. Somatic and Germline
Sherborne AL; Lavergne V; Yu K; Lee L; Davidson PR; Mazor T; Smirnoff IV; Horvai AE; Loh M; DuBois SG; Goldsby RE; Neglia JP; Hammond S; Robison LL; Wustrack R; Costello JF; Nakamura AO; Shannon KM; Bhatia S; Nakamura JL
Clin Cancer Res; 2017 Apr; 23(7):1852-1861. PubMed ID: 27683180
[No Abstract] [Full Text] [Related]
12. Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.
Lavergne V; Sabnis A; Tupule A; Davidson PR; Kline C; Matthay K; Nicolaides T; Goldsby R; Braunstein S; Fogh SE; Sneed PK; Menzel P; Nakamura A; DuBois SG; Haas-Kogan DA; Nakamura JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e647-e654. PubMed ID: 31815884
[TBL] [Abstract][Full Text] [Related]
13. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Imamura T; Hasegawa D; Inoue A; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Kiyokawa N; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Cancer Med; 2023 May; 12(10):11264-11273. PubMed ID: 37021926
[TBL] [Abstract][Full Text] [Related]
15. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
